Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Vehicle-Controlled Study of the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus
Conditions
Interventions
Ruxolitinib cream
Vehicle cream
Locations
24
United States
Cahaba Dermatology
Birmingham, Alabama, United States
Medical Dermatology Specialists Phoenix
Phoenix, Arizona, United States
Mayo Clinic Arizona
Scottsdale, Arizona, United States
Wallace of Beverly Hills
Los Angeles, California, United States
Northshore Medical Group Dermatology Skokie
Skokie, Illinois, United States
Dawes Fretzin Clinical Research Group Llc
Indianapolis, Indiana, United States
Start Date
November 23, 2022
Primary Completion Date
October 2, 2023
Completion Date
February 26, 2024
Last Updated
October 24, 2024
Lead Sponsor
Incyte Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions